May 15, 2018 Media Coverage from ARCH Venture Partners | Share Co-founder and Managing Director Robert Nelsen Speaks with Xconomy on Biotech and Big Pharma
May 15, 2018 Portfolio News from ARCH Venture Partners | Share Nohla Therapeutics Announces Closing of $45 Million Series B Financing
May 14, 2018 Portfolio News from ARCH Venture Partners | Share Beam Therapeutics Founded by Gene Editing Pioneers to Create Precision Genetic Medicines with Base Editing
May 8, 2018 Portfolio News from ARCH Venture Partners | Share CStone Raises $260 million in Series B Financing to Advance Novel Cancer Therapies
May 7, 2018 Portfolio News from ARCH Venture Partners | Share Unity Biotechnology, Inc. Announces Closing of Initial Public Offering
May 2, 2018 Portfolio News from ARCH Venture Partners | Share insitro: Rethinking drug discovery using machine learning
April 17, 2018 Portfolio News from ARCH Venture Partners | Share GRAIL Announces Data from Prototype Blood Tests for Early Cancer Detection
April 3, 2018 Media Coverage from ARCH Venture Partners | Share Robert Nelsen named #5 on Forbes Midas List 2018
March 27, 2018 Portfolio News from ARCH Venture Partners | Share Hua Medicine Raises $117.4 Million in Series D & Series E Financing
March 19, 2018 Portfolio News from ARCH Venture Partners | Share UNITY Biotechnology, Inc. Completes $55 Million Series C Financing
March 15, 2018 Portfolio News from ARCH Venture Partners | Share Arbor Biotechnologies Discovers New CRISPR System Utilizing its Discovery Platform
January 22, 2018 Portfolio News from ARCH Venture Partners | Share Celgene Corporation to Acquire Juno Therapeutics, Inc., Advancing Global Leadership in Cellular Immunotherapy
